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The Role of RPE Cell-Associated VEGF189 in Choroidal
Endothelial Cell Transmigration across the RPE
Haibo Wang,1 Pete Geisen,1 Erika S. Wittchen,2 Bradley King,1 Keith Burridge,2
Patricia A. D’Amore,3 and M. Elizabeth Hartnett1,4
PURPOSE. To determine the role of vascular endothelial growth
factor 189 (VEGF189) in choroidal endothelial cell (CEC) mi-
gration across the retinal pigment epithelium (RPE) and to
explore the molecular mechanisms involved.
METHODS. Using real-time PCR, the expression of VEGF splice
variants VEGF121, VEGF165, and VEGF189 was determined in
human RPE from donor eyes, cultured human RPE in contact
with CECs exposed to hydrogen peroxide (H2O2) or hypoxia,
and RPE/choroid specimens from mice treated with laser to
induce choroidal neovascularization (CNV). Activation of VEGF
receptors (VEGFRs), phosphoinositol 3-kinase (PI-3K) or Rac1
was measured in CECs cocultured in contact with RPE exposed
to peroxide or silenced for VEGF189 expression. Migration of
CECs across the RPE was determined using fluorescence mi-
croscopy.
RESULTS. VEGF189 expression was increased in human RPE from
aged compared with young donor eyes and from mouse RPE/
choroids after laser to induce CNV. VEGF189 was also upregu-
lated in human RPE challenged with peroxide, hypoxia, or
cultured in contact with CECs. CEC migration across RPE was
greater after RPE exposure to peroxide to induce VEGF189;
VEGFR2 and Rac1 activities were also increased in these CECs.
When CECs were cocultured with RPE silenced for VEGF189,
VEGFR2 and Rac1 activities in CECs were significantly reduced,
as was CEC migration across the RPE. Inhibition of Rac1 activ-
ity significantly inhibited CEC transmigration without affecting
PI-3K activity.
CONCLUSIONS. RPE-derived cell-associated VEGF189 facilitates
CEC transmigration by Rac1 activation independently of PI-3K
signaling and may have importance in the development of
neovascular AMD. (Invest Ophthalmol Vis Sci. 2011;52:
570–578) DOI:10.1167/iovs.10-5595
Age-related macular degeneration (AMD) is a leading causeof nonreversible blindness worldwide.1 Vision loss most
often occurs in advanced forms, which are atrophic AMD
(geographic atrophy) and neovascular AMD. In atrophic AMD,
there is loss of the photoreceptors, retinal pigment epithelium
(RPE), and choriocapillaris in the outer retina, whereas in
neovascular AMD, blood vessels from the choroid grow into
Bruch’s membrane, the subretinal space, and neurosensory
retina. Neovascular AMD accounts for 80% of the severe cen-
tral vision loss (legal blindness) in AMD.
The steps involved in the development of neovascular AMD
are complex and incompletely understood. From clinicopath-
ologic studies, it appears that 50% of vision-threatening neo-
vascular AMD occurs when choroidal endothelial cells (CECs)
are induced to migrate toward the RPE and make contact with
the RPE and its extracellular matrix. After contact with RPE,
CECs can migrate across the RPE into the neurosensory retina,
where choroidal neovascularization (CNV) develops.2,3 The
normal outer neurosensory retina lacks blood vessels, and the
new blood vessels that develop often leak and bleed, causing
vision loss. Thus, the migration of CECs across the RPE and the
development of CNV in the neurosensory retina are important
events leading to severe vision loss from neovascular AMD.
The RPE barrier, which is composed of a monolayer of
polarized epithelial cells linked by tight junctions, is important
in several processes necessary for fine visual acuity.4 There is
evidence that under normal conditions the RPE barrier com-
partmentalizes angiogenic agonists predominantly by secreting
them basally, whereas inhibitors are secreted apically.5 In ag-
ing eyes, it has been postulated that the RPE becomes less able
to handle its metabolic load6,7 and stressors such as light,
hypoxia,8 and inflammation,9 leading to RPE barrier compro-
mise.10,11 In addition, these stressors have also been shown to
result in the increased expression of angiogenic factors.12 We
previously reported that RPE-CEC contact led to reduced RPE
barrier properties10 and facilitated CEC migration across the
RPE, induced by vascular endothelial growth factor (VEGF).13
VEGF-A (hereafter referred to as VEGF) is one angiogenic
factor produced by RPE. Five splice variants or isoforms of
VEGF in humans and three in mice are alternatively spliced
from a single gene, and each has different biological functions
and bioavailability.14–16 The most studied human splice vari-
ants (mouse analogs in parentheses) are VEGF189 (VEGF188),
which is predominantly cell associated, VEGF121 (VEGF120),
which is soluble, and VEGF165 (VEGF164),
17 which has inter-
mediate properties. Experimental studies using genetically
modified mice indicated that VEGF signaling was important in
the formation of CNV in AMD.16,18–21 Clinical experience
reveals that inhibition of all splice variants of VEGF with a
humanized monoclonal antibody against VEGF led to improved
visual acuity in approximately 40% of cases.22 However, con-
cern is raised about the safety of using agents to block all VEGF
functions because VEGF is also a survival factor for CEC and
RPE.23,24 Given that VEGF has beneficial effects, it would be
desirable to develop a strategy to inhibit only its pathologic
functions.1
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We studied the role of cell-associated VEGF188/189 (term
includes the mouse and human analogs) in neovascular AMD.
Specifically, we hypothesized that RPE-derived VEGF189 would
be upregulated in response to certain stressors or early events
that occur in advanced AMD and that this splice variant would
facilitate CEC migration across RPE, a critical step in the de-
velopment of vision-threatening neovascular AMD. To test this
hypothesis, we used a coculture model that mimicked the
physiologic positions of RPE and CECs and controlled for
contact between the two cell types. We determined the ex-
pression of VEGF189 in young and old human donor RPE
specimens and in mouse RPE after treatment with laser to
induce CNV. We investigated the molecular mechanisms and
the role of VEGF189 in CEC transmigration. Our results reveal
that RPE-derived VEGF189 plays a critical role in facilitating CEC
migration across the RPE by activating VEGFR2 and Rac1 in
CECs in a pathway that appears independent of the phospho-
inositol 3-kinase (PI-3K) signaling pathway.
METHODS
Animals
Adult transgenic mice bred to express only the cell-associated VEGF188
splice variant on a C57Bl/6 background were used to isolate murine
RPE (mRPE188/188).
19 Appropriate controls were age-matched wild-
type mice of the same genetic background (mRPE-WT). RPE and CECs
were isolated and grown in culture, as described. All animal experi-
ments were approved by the Institutional Animal Care and Use Com-
mittees of the University of North Carolina and the Schepens Eye
Research Institute in accordance with National Institutes of Health
guidelines for the care and use of laboratory animals and adhering to
the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.
Human RPE RNA Extraction
Posterior eyecups removed from human eyes within 24 hours of death
were obtained from the North Carolina Eye Bank, and RPE were
immediately collected for RNA extraction. All studies involving human
eyes were done adhering to the tenets of the Declaration of Helsinki
for research involving human tissue.
Cell Culture
Human fetal RPE (hfRPE) were isolated from donor eyes (Advanced
Bioscience Resources, Alameda, CA) of 15- to 18-week-old fetuses,
following a previously published protocol25; passages 1 to 3 hfRPE
were used in experiments. Human CECs were isolated from donor eyes
from the North Carolina Eye Bank, Inc. (Winston-Salem, NC). Primary
CECs were isolated as previously described.13 Passages 2 through 5
cells were used in experiments. ARPE-19 cells were obtained from
ATCC (Rockville, MD) and grown in Dulbecco’s modified Eagle’s
medium/F12 (Invitrogen) (DMEM/F-12) plus 10% FBS and penicillin-
streptomycin. Cells below passage 18 were used for experiments.
Primary mouse RPE (mRPE) was isolated using a modified protocol,
as previously described by Gibbs et al.26 Passages 3 to 5 cells were
used in experiments. Cells were confirmed as RPE and not endo-
thelial cells or fibroblasts by positive pan-cytokeratin staining (Ab-
cam, Cambridge, MA).
Coculture Studies
For biochemical assays, CECs were grown on inserts (Transwell; Corn-
ing, Corning, NY) inserts with 1-m diameter pores that were too small
to allow cell migration but still allowed CEC cell processes to make
contact with the basal aspects of the RPE grown on the underside of
the inserts.27 In some experiments, hfRPE was incubated with H2O2. In
others, ARPE-19 cells were transfected with VEGF189 siRNA, as de-
scribed below. Twenty-four hours after contact and indicated treat-
ments, CECs were collected from the tops of the inserts (Transwell;
Corning) and were processed for PI-3K and Rac1 activity assays and
VEGFR2 phosphorylation, as described in the following sections. The
total protein was determined using the BCA protein assay (Thermo
Scientific, Pittsburgh, PA), and equivalent amounts were used for each
assay. PI-3K and Rac1 activity assays were performed as previously
described using immunoprecipitation to probe phospho-Akt1 and GST-
PBD pull-down to detect active Rac1.27 Phospho-VEGFR2 was mea-
sured, as previously described,28 by immunoprecipitation to detect
phospho-VEGFR2. Western blot analysis was developed with enhanced
chemiluminescence (ECL; Amersham, Piscataway, NJ) and analyzed
using gel analysis software (Un-Scan-It; Silk Scientific, Orem, UT).
Transmigration Assays
Transmigration was measured as previously described.13 ARPE-19 or
hfRPE cells were plated as for coculture assays on inserts (Transwell;
Corning) with 8-m pores. Before plating, CECs were fluorescently
labeled with cell-labeling solution (Vybrant Dio, V22886; Molecular
Probes, Invitrogen, Carlsbad, CA) in accordance with the manufac-
turer’s protocol. Labeled CECs were then plated into each insert.
Forty-eight to 72 hours after plating, migrated CECs were counted
using fluorescence microscopy.
VEGF189 Knockdown
VEGF189 gene silencing was performed in ARPE-19 cells using custom-
designed small interfering RNA (siRNA; AAAUCAGUUCGAGGAAAG-
GTT (sense) and CCUUUCCUCGAACUGAUUUTT (antisense) pur-
chased from Ambion (Austin, TX). Nontargeting control siRNA was
used as a negative control (4390843; Applied Biosystem, Foster City,
CA). ARPE-19 cells were transfected with the siRNA duplex (JetPRIME;
Polyplus Transfection, Illkirch, France) and then were plated onto the
undersides of inserts (Transwell; Corning). Twenty-four hours later,
ARPE-19 cells were plated onto the inserts (Transwell; Corning) for
coculture and transmigration assays.
Inhibition of Rac1 Activity
Rac1 inhibition was achieved by expression of Rac binding domain of
Rac1 effector POSH (GFP-POSH-RBD) in CECs, as described previ-
ously,27 and were compared with control GFP alone. Briefly, GFP-
POSH-RBD or GFP was transfected into CECs using DNA transfection
(JetPRIME; Polyplus Transfection) before CECs were plated onto in-
serts.
Real-Time Quantitative PCR
Total RNA was extracted (RNeasy Mini Kit; Qiagen Valencia, CA).
Assays were performed using the real-time PCR system (7500; Applied
Biosystems). Briefly, 1 g total RNA was reverse-transcribed into cDNA
using a cDNA kit (High Capacity; Applied Biosystem) according to the
manufacturer’s protocol. Each reaction (TaqMan, 16 L; Applied Bio-
systems) contained 20 ng cDNA, 8 L mix (TaqMan PCR MasterMix;
Applied Biosystems), and 1 M forward primer, 1 M reverse primer,
and 1 M probe. All the samples were analyzed for human -actin
expression in parallel as an internal control. Gene expression was
normalized to the expression level of -actin. Primers and probes were
as follows: human VEGF121, 5-CAT AGG AGA GAT GAG CTT CC-3
(forward), 5-CCT CGG CTT GTC ACA TTT TTC T-3 (reverse), FAM-
CA GCA CAA CAA ATG TGA ATG CAG ACC A-TAMRA (probe); for
human VEGF165, 5-CAT AGG AGA GAT GAG CTT CC-3 (forward),
5-AAG GCC CAC AGG GAT TTT CT-3 (reverse), FAM-CA GCA CAA
CAA ATG TGA ATG CAG ACC A-TAMRA (probe); for human VEGF189,
5-CCA AAG AAA GAT AGA GCA AGA C-3 (forward), 5-AGG ACT TAT
ACC GGG ATT TCT-3 (reverse), FAM-TG CCC CTT TCC CTT TCC TCG
AAC TG-TAMRA (probe).
Laser-Injury CNV Model
The laser-induced choroidal neovascularization (CNV) model was carried
out as previously described.29 Three to six spots of laser photocoagulation
IOVS, January 2011, Vol. 52, No. 1 VEGF189 Facilitates CEC Migration 571
(532 nm, 200 mW, 100 ms, 75 m; OcuLight GL, Iridex, CA) were applied
around the optic nerve. Seven days after laser injury, mice were euthana-
tized and posterior eyecups were harvested and kept in tissue storage
reagent (RNAlater; Ambion) at 80°C for RNA extraction. The mRNA of
VEGF splice variants was analyzed by RT-PCR.
Statistical Analysis
Significant differences between groups were determined by either one-
way or two-way ANOVA. P  0.05 was considered statistically significant.
RESULTS
VEGF Splice Variants Expression in Human and
Murine RPE
To determine the effect of RPE stressors relevant to human
neovascular AMD, such as aging, hypoxia, and H2O2, we first
measured the expression of VEGF splice variants VEGF121,
VEGF165, and VEGF189 in aged (70 years) and young (20–40
years) human RPE obtained from eye bank eyes. As shown in
Figure 1A, in the RPE of young donors, the expression of
VEGF165 (cycle threshold [CT] value, 30) was higher than that
of VEGF121 and VEGF189 (CT value, 32). The expression of all
VEGF splice variants was upregulated in RPE from older donor
eyes compared with RPE from younger donors with an in-
crease of approximately 26-fold for VEGF189, 23-fold for
VEGF121, and 9-fold for VEGF165. Next, hfRPE was challenged
with hypoxia or oxidative stress. When hfRPE was incubated
with different doses of H2O2 (at a final concentration of 50
M-600 M) for 16 hours, a selective increase in the expres-
sion of VEGF189 occurred with 600 M H2O2 (Fig. 1B). Incu-
bation with 1% oxygen resulted in the upregulation of all
splice variants, with the increase in VEGF189 expression
over room air slightly greater than that of the other splice
variants (Fig. 1C).
The effect of RPE-CEC contact on the expression of VEGF
splice variants was analyzed in hfRPE-CEC cocultures. As
shown in Figure 1D, contact with CECs led to a much greater
expression of VEGF189 in RPE compared with noncontacting
coculture or solo RPE culture (P  0.0028), but there was little
change in VEGF121 and VEGF165 expression in these condi-
tions. There was no significant change in expression of VEGF
splice variants in CECs (Fig. 1E). To determine the expression
of VEGF189 in CNV in vivo, VEGF splice variants were mea-
sured in isolated mouse RPE/choroids from wild-type mice
treated with laser. All three splice variants were induced in
retinas that had been treated with laser injury compared with
nonlasered controls (Fig. 1F). There was a 3-fold increase in the
mRNA expression of VEGF188 (P  5.5  10
6).
VEGF189 Effect on CEC Migration across RPE
As shown in Figures 1B and 1D, preferential upregulation of





















































































































FIGURE 1. Expression of VEGF iso-
forms in human and mouse RPE. The
expression of VEGF isoforms was
measured by RT- PCR in (A) human
RPE from young (20 years old) and
old (70 years old) donors. ***P 
0.0001 vs. young (n  3); the num-
ber on the top of the bar means
mRNA expression level of VEGF
splice variants for real-time PCR. (B)
hfRPE treated with H2O2 (600 M)
for 16 hours. ***P  0.0001 vs. con-
trol (n  6). (C) hfRPE incubated
under hypoxic conditions 1% O2.
***P  0.0001 vs. 21% O2 (n  3).
(D) hfRPE solo, noncontact, and con-
tact with CECs. *P  0.05, ***P 
0.0001 vs. solo (n  6). (E) CECs
solo, noncontact, and contact with
hfRPE (n  3). (F) Mouse RPE 7 days
after laser injury CNV. *P  0.05 and
***P  0.0001 vs. control (n  6). All
data are shown as mean  SEM.
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contact with CECs. Thus, we next sought to determine
whether this specific upregulation of cell-associated VEGF in
RPE would facilitate CEC migration across the RPE. To test this
possibility, RPE and CECs were plated for transmigration as-
says. hfRPE was plated on the underside of inserts (Transwell;
Corning) and allowed to grow for 3 days before the addition of
CECs and an additional 2 days of incubation. Sixteen hours
before the termination of the experiment, H2O2 (to a final
concentration of 600 M) was added to the well containing the
RPE. VEGF189 mRNA was upregulated in hfRPE treated with
H2O2 (Fig. 1B). The expression of VEGF splice variants in solo
CECs treated with H2O2 was unaffected compared with con-
trol (Fig. 2A). H2O2 treatment led to a 2-fold increase in CEC
migration across the hfRPE (Fig. 2B; P  0.0014). Transmigra-
tion assays were also performed using murine VEGF188/188 RPE
(mRPE188/188) and human CECs. Migration of CEC across RPE was
higher with RPE that produced only VEGF188 (mRPE188/188) com-
pared with RPE that expressed all VEGF splice variants (mRPE WT)
(Fig. 2C; P  0.011).
To confirm the effect of RPE-derived cell-associated
VEGF189 on CEC migration across RPE, we depleted endoge-
nous VEGF189 in ARPE-19 cells using siRNA. Two different
siRNA sequences were designed to target VEGF189, and a ran-
dom sequence nontargeting siRNA was used as a negative
control. To test the efficiency of VEGF189 knockdown, the
expression of VEGF splice variants was measured in ARPE-19
cells by real-time PCR 48 hours after transfection with siRNA.
As shown in Figure 3A, both siRNA sequences against VEGF189
knocked down the expression of VEGF189 without affecting
the expression level of VEGF121 and VEGF165. Given that siRNA
sequence A led to a slightly greater knockdown, this siRNA
sequence was used in transmigration assays. Twenty-four hours
after siRNA transfection, ARPE-19 cells were plated onto the
underside of the inserts (Transwell; Corning), and 4 hours later
CECs were plated into the inserts. After 48 hours, CEC migra-
tion across the VEGF189-silenced ARPE-19 was decreased ap-
proximately 40% compared with controls (6960.78  2248.45/
cm2 transmigrated CECs across VEGF189-silenced RPE vs.
10,261.51  1187.32/cm2 transmigrated CECs across control
RPE) (Fig. 3B; P  0.0098).
VEGF189 Effect on Phosphorylated VEGFR2
in CECs
To test our hypothesis that RPE-derived VEGF189 by H2O2 and
in contact with CECs triggers signaling to facilitate CEC migra-
tion through binding VEGFRs in CECs, we first confirmed that
VEGFR1 and VEGFR2 were expressed in CECs using real-time






















































FIGURE 2. RPE-derived VEGF189/188 facilitates CEC migration across
RPE. (A) Expression of VEGF splice variants in solo CECs treated with
or without H2O2 (n  3); CEC transmigration was measured in cocul-
tures of RPE and CEC. (B) CEC transmigration was measured when the
cocultured hfRPE was incubated in the presence or absence of 600 M
H2O2 for 16 hours H2O2 treatment of hfRPE increased CEC transmi-
gration. **P  0.001 vs. control (n  6). (C) CEC migration across the
filter when cultured alone (solo) or with mRPE-WT or mRPE188/188.
CEC transmigration was highest when cocultured with mRPE188/188.
*P  0.05 and ***P  0.0001 vs. solo and ###P  0.0001 vs. mRPE (n 


















































FIGURE 3. Knockdown of VEGF189 in RPE decreases CEC transmigra-
tion. (A) mRNA levels of VEGF isoforms in ARPE-19 cells transfected
with VEGF189 siRNA were measured by RT-PCR. Nontargeting siRNA
was used as a negative control. Both VEGF189 siRNA sequences A and
B specifically reduced VEGF189 while not affecting expression of the
other isoforms. ***P  0.0001 vs. control (n  6). (B) CEC transmigra-
tion assay was performed using ARPE-19 cell monolayer that had been
depleted of VEGF189 by siRNA. CEC transmigration was decreased
when cocultured with ARPE-19 with reduced VEGF189. *P  0.05 vs.
control siRNA (n  6). All data are described as mean  SEM.
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VEGFR2 mRNA than in VEGFR1 mRNA. We then measured the
activation of both VEGFRs in CECs that had been grown in
contact with RPE. hfRPE was grown in contact with CECs for
24 hours, and, during the last 16 hours of incubation, hfRPE,
was incubated with H2O2 to induce the expression of VEGF189
(Fig. 1B). After 16 hours of incubation, CECs were collected
and analyzed for phosphorylated VEGFR1 and VEGFR2. Ty-
rosine phosphorylation of VEGFR2 in CECs was significantly
increased when hfRPE was treated with 600 M H2O2 (Fig.
4B). VEGFR1 phosphorylation was unchanged (Fig. 4C). As a
control, to rule out the possibility that the increase in VEGFR2
phosphorylation in CECs occurred through a direct effect of
H2O2 on CEC VEGFR2, we measured the phosphorylation of


























































H2O2 0           600 µM
Total-VEGFR1
siRNA      Control        VEGF189
p-VEGFR1
Total-VEGFR1
FIGURE 4. CEC contact with hfRPE
leads to VEGFR2 increased phos-
phorylation in CECs. (A) Expres-
sion of VEGFR1 and VEGFR2 in
CECs (n  3). Immunoprecipita-
tion of phospho-VEGFR2 and
VEGFR1 in CECs. CECs were grown
in contact with hfRPE. During the
last 16 hours of contact, hfRPE was
incubated with 600 M H2O2. H2O2
treatment of RPE increased the
phosphorylation of VEGFR2 in
CECs (B) but did not affect VEGFR1
phosphorylation (C; representative
blot shown). The bar graph on the
right shows phospho-VEGFR2
band density normalized to total
VEGFR2. **P  0.001 vs. control
(PBS) (n  3). (D) Representative
blots showing that the phosphory-
lation of VEGFR1 and VEGFR2 was
unchanged in solo CECs treated
with H2O2. CECs grown in contact
with ARPE-19 cells were trans-
fected with VEGF189 siRNA. After
24 hours of contact, CECs were col-




blot analysis. VEGFR2 phosphorylation
was decreased (E), but VEGFR1 phos-
phorylation was unchanged in CECs
cocultured in contact with RPE
with reduced VEGF189 (F). The bar
graph on the right shows phospho-
VEGFR2 band density normalized
to total VEGFR2. *P  0.05 vs. con-
trol siRNA (n  3) and a represen-
tative blot of phospho-VEGFR1.
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There was no significant change in VEGFR1 or VEGFR2 phos-
phorylation in solo CECs treated with H2O2 compared with
control (Fig. 4D).
To determine whether the activation of VEGFR2 and
VEGFR1 in CECs was due to H2O2-induced upregulation of
RPE-associated VEGF189, VEGF189 was depleted by siRNA in
ARPE-19 cells, and cells plated onto inserts 24 hours after
transfection. CECs were plated into the inserts 4 hours later.
After 24 hours of coculture, phosphorylation of VEGFR2 in
CECs was decreased in cocultures in which ARPE-19 had been
silenced for VEGF189 (Fig. 4E), supporting the hypothesis that
RPE-derived VEGF189 activated VEGFR2 in CECs. However,
VEGFR1 phosphorylation was unchanged under the same con-
ditions (Fig. 4F).
VEGF189 Effect on CEC Transmigration and
Activity of Rac1
Results indicated that oxidative stressor H2O2 upregulated
VEGF189 in the RPE, facilitating CEC migration across RPE by
activating VEGFR2 in CECs. We previously reported that PI-3K
and Rac1 were activated in CECs grown in contact with RPE, and
these signaling pathways were important in CEC migration across
the RPE.27 Therefore, we determined whether Rac1 and PI-3K
signaling were triggered by RPE cell-associated VEGF189 and
whether they were necessary for CEC transmigration. Cocul-
ture assays were performed, and the activities of Rac1 and
PI-3K were determined in CECs. Rac1 was activated in CECs
grown in contact with mRPE188/188 compared with wild-type
mRPE (Fig. 5A). Coculture of CECs with hfRPE preincubated
with H2O2 also led to the activation of Rac1 in CECs (Fig. 5B),
but not to an increase in Akt1 phosphorylation (Fig. 5C). There
was no difference in Rac1 activation in solo CECs treated with
H2O2 compared with control (Fig. 5D), reducing the possibility
that H2O2 treatment might have directly activated Rac1 in
CECs.
To further examine the effect of RPE-derived VEGF189 in the
activation of CEC Rac1 activation, Rac1 activity assays were
performed in CECs grown in coculture with ARPE-19 trans-
fected with siRNA against VEGF189. As shown in Figure 6A,
Rac1 activity in CECs was decreased when grown in contact
with coculture with ARPE-19 silenced for VEGF189 compared
with control siRNA. Akt1 phosphorylation in CECs was not
affected by knockdown of VEGF189 in ARPE-19 cells (Fig. 6B),
consistent with results shown in Figure 5C. To determine
whether Rac1 activation was necessary for CEC transmigration
stimulated by RPE-derived VEGF189, we used a construct con-
taining the Rac-binding domain of Rac1 effector POSH (GFP-
POSH-RBD), which we previously found inhibits Rac1 activity
in CECs.27 The construct and a control GFP construct were
transfected into CECs before CEC plating. The transmigration
assay was performed 48 hours after hfRPE-CEC coculture. Dur-
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H2O2 0           600 µM
Active-Rac1
Total-Rac1
H2O2 0             600 µM
D
FIGURE 5. Coculture of CECs with
RPE expressing elevated VEGF189/188
leads to increased Rac1 activity. Rac1
activity assay was measured in CECs
grown in contact with (A) mRPE-WT
and mRPE188. The bar graph on the
right shows active-Rac1 band density
normalized to total Rac1. *P  0.05
vs. mRPEWT (n  3). (B) hfRPE
treated with 600 M H2O2 for 16
hours. After 24 hours of contact,
CECs were collected for the detec-
tion of active Rac1 and total Rac1 by
GST-PBD pull-down and Western
blot analysis, as described. Rac1 ac-
tivity was increased with both treat-
ments. The bar graph on the right
shows active-Rac1 band density nor-
malized to total Rac1. **P  0.001 vs.
control (PBS) (n  3). (C) PI-3K ac-
tivity using phosphorylation of Akt-1
as a readout was measured in CECs
grown in contact with hfRPE treated
with H2O2 as in B. CECs were then
collected for the detection of phos-
pho-Akt and total Akt by immunopre-
cipitation and Western blot analysis
as described in Experimental Proce-
dures. Upregulation of VEGF189 by
H2O2 treatment of RPE does not af-
fect phosphorylation of Akt-1 in
CECs. The bar graph on the right
shows phospho-Akt (Ser473) band
density normalized to total Akt1.
P  0.05 vs. control (PBS) (n  3).
(D) Representative blot showing
that Rac1 activity was unchanged in
solo CECs treated with H2O2.
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challenged with 600 M H2O2. As shown in Figure 6C, and
consistent with the results shown in Figure 2B, CEC transmi-
gration increased significantly when hfRPE were incubated
with H2O2 (P  0.04), but this effect was inhibited when Rac1
activity was decreased in CECs by transfection with GFP-POSH.
These results provide support that VEGF189 facilitates CEC
migration across the RPE, mediated by VEGFR2-induced acti-
vation of Rac1 in CECs.
DISCUSSION
VEGF-A is the most widely studied ligand of the VEGF family,
and it plays an important role in the formation of CNV by
several mechanisms,30,31 including the release of matrix met-
alloproteinases,32 endothelial cell survival,33 CEC migration
and proliferation,34–36 increased permeability,37 and integrin
turnover with endothelial migration.38
In healthy young mouse RPE/choroidal specimens, VEGF164
and VEGF120 are the dominant splice variants, whereas
VEGF188 is virtually undetectable.
39 Our data from human eye
samples showed that VEGF165 was also the dominant splice
variant in young adult RPE. However, in contrast to that found
with VEGF165, the change in mRNA expression levels of
VEGF189 and VEGF121 were significantly increased in RPE from
aged compared with young donor eyes. The observation that
VEGF189 was increased in RPE from aged donors suggested that
VEGF189 may play an important role in AMD. To mimic the
stress relevant to human neovascular AMD in vitro, hfRPE was
cultured under hypoxic conditions or after exposure to H2O2.
Notably, we observed that the expression of VEGF189 was
preferentially upregulated in response to this stress. The up-
regulation of VEGF188 was also seen in RPE/choroids from mice
that developed CNV after laser injury. These lines of evidence
provide strong support that RPE-derived VEGF189, though min-
imally expressed in youth, is upregulated by stressors postu-
lated to play a role in AMD, including hypoxia, oxidative stress,
and contact between RPE and CECs before the development of
neurosensory retinal CNV.
We next tested the hypothesis that RPE-derived VEGF189
plays an important role in CEC transmigration. Contact be-
tween RPE and CECs is an important step preceding the de-
velopment of vision-threatening neovascular AMD.2,3 Given
that there are no animal models or clinical studies that allow
direct examination of the effects of contact between RPE and
CECs, we used an in vitro coculture model to study the effects
of RPE and CEC interactions13 and contact on signaling path-
ways within each cell type and on CEC migration across the
RPE. Results obtained with this model demonstrated that the
expression of VEGF189, compared with that of other VEGF
splice variants, was preferentially upregulated in RPE grown in
contact with CECs and that it contributed to CEC migration
across the RPE. That there was only a 40% reduction in trans-
migration after VEGF189 knockdown indicates either that the
small remaining amount of VEGF189 resistant to knockdown is
enough to trigger signaling in CECs or that other factors that
are also partially cell associated, including VEGF165, may be
acting in parallel. We also showed that the RPE-derived
VEGF189 binds to and activates VEGFR2 on CECs to trigger















































































FIGURE 6. RPE-derived VEGF189 stim-
ulates CEC transmigration mediated by
Rac1 activation. Activities of Rac1 (A)
and PI-3K (B) were measured in CECs
grown in contact with ARPE-19 cells
with reduced VEGF189. Twenty-four
hours after contact, CECs were col-
lected for the detection of active Rac1
and phospho-Akt by GST pull-down
and immunoprecipitation. Whole cell
lysates were used to detect total Rac1
and Akt by Western blot analysis.
Knockdown of VEGF189 decreased
Rac1 activity compared with control
siRNA, whereas p-Akt remained un-
changed. The bar graph on the right
shows active-Rac1 or phospho-Akt
band density normalized to total Rac1
or total Akt1. *P  0.05 vs. control
siRNA (n  3). (C) CEC transmigration
assay was performed using hfRPE and
CECs in which Rac1 activity had been
inhibited by transfection with GFP-
POSH-RBD. Twenty-four hours after
transfection, CECs were added, and
transmigration was measured after 48
hours. During the last 16 hours of con-
tacting coculture, hfRPE was incu-
bated with 600 M H2O2. CECs in
which Rac1 activity was inhibited by
expressing GFP-POSH did not exhibit
increased transmigration when cocul-
tured with H2O2-treated hfRPE com-
pared with cells expressing GFP alone.
***P  0.0001 vs. GFP alone (n  6).
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Rac1 is one of the small Rho family GTPases activated by
guanine nucleotide exchange factors. In the GTP-bound acti-
vated state, Rac1 can modulate cell behavior through effector
proteins. Rac1 is most often associated with cell motility and
migration40–42 as a key regulator of actin polymerization and
reorganization in cell-membrane protrusions during directed
endothelial cell migration.43 Rac1 has been shown both to
activate and to be activated by PI-3K. PI-3K, in turn, can be
activated by multiple stimuli, such as integrins44 and receptor
growth-factor binding,31 including VEGF.45,46 Furthermore, it
is an important mediator of signal transduction downstream of
a variety of cell surface receptors, including VEGFR2.47
One well-known function of PI-3K is the regulation of cell
migration. Endothelial cell chemotaxis is dependent on PI-3K
activation of intracellular signaling cascades.48 There are also
other kinases, such as c-Jun N-terminal kinase (JNK),49 p38,
extracellular signal-regulated protein kinase (ERK), and mito-
gen-activated protein kinases (MAPKs), that play important
roles in the regulation of cell movement,50 and these pathways
may also play a role in neovascular AMD. We previously iden-
tified a signaling pathway involving Rac1 and PI-3K that medi-
ates CEC migration across an RPE monolayer in response to a
VEGF gradient.27 Here, we studied the splice variant most
greatly upregulated in RPE in aged eyes and in response to
contact with CECs, stressors relevant to human neovascular
AMD, to specifically determine its role in possible PI-3K–trig-
gered Rac1 activation and endothelial migration. Our results
show that VEGF-induced CEC migration involves Rac1 but not
PI-3K. In light of our previous findings,27 these data suggest the
existence of parallel pathways involving PI-3K through which
splice variants other than VEGF189, such as VEGF165, might
stimulate CEC transmigration. Our results do not preclude the
role of other kinases, such as p38 MAPK or ERK, in CEC
migration possibly involved downstream of Rac1.
Our findings suggest that stressors relevant to human neo-
vascular AMD induce the expression of soluble and cell-asso-
ciated VEGF splice variants in RPE. Increased levels of soluble
VEGF splice variants, such as VEGF121 and VEGF165, provide a
chemotactic gradient for migrating CECs, which, on making
contact with the RPE, lead to RPE barrier compromise10 and
further upregulation of VEGF189. VEGF2 phosphorylation in
CECs leads to the activation of PI-3K and Rac1 and contributes
to their transmigration.27 This study provides evidence that
RPE-derived cell-associated VEGF188/189, which is upregulated
by age and contact with CECs, may play an important role in
the development of neurosensory retinal CNV in neovascular
AMD.
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